Literature DB >> 6304501

Effects of adenovirus infection on rRNA synthesis and maturation in HeLa cells.

C L Castiglia, S J Flint.   

Abstract

The production of cytoplasmic and nucleolar rRNA species was examined in HeLa cells infected with high multiplicities of adenovirus type 5. Both 28S and 18S rRNA newly synthesized in infected cells ceased to enter the cytoplasm as reported previously (N. Ledinko, Virology 49: 79-89, 1972; H. J. Raskas, D. C. Thomas, and M. Green, Virology 40: 893-902, 1970). However, the effects on 28S cytoplasmic rRNA were observed considerably earlier in the infectious cycle than those on 18S rRNA. The inhibition of cellular protein synthesis and of the appearance in the cytoplasm of labeled cellular mRNA sequences (G. A. Beltz and S. J. Flint, J. Mol. Biol. 131: 353-373, 1979) were also monitored in infected cultures. During the later periods of an infectious cycle, from 18 h after infection, nucleolar rRNA synthesis and processing and exit of 18S rRNA from the nucleus were inhibited, probably reflecting the failure of infected cells to synthesize normal quantities of ribosomal proteins. The earliest responses of cellular RNA metabolism to adenovirus infection were, however, the rapid and apparently coordinate reductions in the levels of newly synthesized 28S rRNA and cellular mRNA sequences entering the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304501      PMCID: PMC368582          DOI: 10.1128/mcb.3.4.662-671.1983

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  The polypeptides of adenovirus. 3. Synthesis in infected cells.

Authors:  D O White; M D Scharff; J V Maizel
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

2.  Effects of valine deprivation on ribosome formation in HeLa cells.

Authors:  B E Maden; M H Vaughan; J R Warner; J E Darnell
Journal:  J Mol Biol       Date:  1969-10-28       Impact factor: 5.469

3.  Selective suppression of nucleolar RNA metabolism in the absence of protein synthesis.

Authors:  K Higashi; T Matsuhisa; A Kitao; Y Sakamoto
Journal:  Biochim Biophys Acta       Date:  1968-09-24

4.  Synthesis of ribosomal proteins in the absence of ribosome maturation in methionine-deficient HeLa cells.

Authors:  B E Maden; M H Vaughan
Journal:  J Mol Biol       Date:  1968-12       Impact factor: 5.469

5.  Biochemical studies on adenovirus multiplication. XIV. Macromolecule and enzyme synthesis in cells replicating oncogenic and nononcogenic human adenovirus.

Authors:  M Piña; M Green
Journal:  Virology       Date:  1969-08       Impact factor: 3.616

6.  Acrylamide gel electrophoresis of HeLa cell nucleolar RNA.

Authors:  R A Weinberg; U Loening; M Willems; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

7.  The effects of methionine deprivation on ribosome synthesis in HeLa cells.

Authors:  M H Vaughan; R Soeiro; J R Warner; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1967-10       Impact factor: 11.205

8.  Ribosome formation in HeLa cells in the absence of protein synthesis.

Authors:  J R Warner; M Girard; H Latham; J E Darnell
Journal:  J Mol Biol       Date:  1966-08       Impact factor: 5.469

9.  Relationship between deoxyribonucleic acid-like ribonucleic acid synthesis and inhibition of host protein synthesis in type 5 adenovirus-infected KB cells.

Authors:  L J Bello; H S Ginsberg
Journal:  J Virol       Date:  1969-02       Impact factor: 5.103

10.  The regulation of RNA synthesis and processing in the nucleolus during inhibition of protein synthesis.

Authors:  M Willems; M Penman; S Penman
Journal:  J Cell Biol       Date:  1969-04       Impact factor: 10.539

View more
  26 in total

1.  Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm.

Authors:  D A Matthews
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism.

Authors:  Ramon A Gonzalez; S J Flint
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

4.  Morphological, Biochemical, and Functional Study of Viral Replication Compartments Isolated from Adenovirus-Infected Cells.

Authors:  Paloma Hidalgo; Lourdes Anzures; Armando Hernández-Mendoza; Adán Guerrero; Christopher D Wood; Margarita Valdés; Thomas Dobner; Ramón A Gonzalez
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

5.  Viral and host cellular transcription in Autographa californica nuclear polyhedrosis virus-infected gypsy moth cell lines.

Authors:  D Guzo; H Rathburn; K Guthrie; E Dougherty
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export.

Authors:  W Huang; S J Flint
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  RNA-binding properties of a translational activator, the adenovirus L4 100-kilodalton protein.

Authors:  D Riley; S J Flint
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells.

Authors:  U C Yang; W Huang; S J Flint
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Relationship between adenovirus DNA replication proteins and nucleolar proteins B23.1 and B23.2.

Authors:  Clemence E Hindley; Andrew D Davidson; David A Matthews
Journal:  J Gen Virol       Date:  2007-12       Impact factor: 3.891

10.  Proteomics analysis of the nucleolus in adenovirus-infected cells.

Authors:  Yun W Lam; Vanessa C Evans; Kate J Heesom; Angus I Lamond; David A Matthews
Journal:  Mol Cell Proteomics       Date:  2009-10-07       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.